Abbvie’s Revenue by Region (2013-2020)

Download

About

This statistic highlights Abbvie’s Revenue by Region on a yearly basis, split between Brazil, Canada, China, France, Germany, Italy, Japan, Spain, The Netherlands, United Kingdom, United States and Other countries.
Subscribe to Pro or Enterprise plans to unlock this feature.
More information
Subscribe to Pro or Enterprise plans to unlock this feature.
Contact the Analyst
Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on reddit
Share on facebook
Share on twitter
Share on linkedin
Share on email

Become a smarter investor today.

Access Business Quant for as low as $19/month

Become a smarter investor today.

Access KPI Data on listed stocks for just $19/month

This statistic highlights Abbvie’s Revenue by Region on a yearly basis from 2013 onwards, split between Brazil, Canada, China, France, Germany, Italy, Japan, Spain, The Netherlands, United Kingdom, United States and Other countries.

Abbvie Inc is an American biopharmaceutical company. The company uses its expertise, dedicated personnel and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases.

Abbvie’s Revenue by Region

Region 2019 2020 Revenue Share in 2020
All other countries $3.99 $3.98 9%
Brazil $0.36 $0.53 1%
Canada $0.81 $0.41 1%
China $0 $1.16 3%
France $0.69 $0.47 1%
Germany $0.91 $0.79 1%
Italy $0.37 $1.05 2%
Japan $1.21 $0.38 1%
Spain $0.47 $1.19 3%
The Netherlands $0.16 $0.45 1%
United Kingdom $0.37 $0.51 1%
United States $23.91 $34.88 76%
Total $33.27 $45.80 100%

(All figures in billions, except percentages)

Abbvie’s total revenue has increased from $33.27 billion in FY 2019 to $45.80 billion in FY 2020, which is a 38% increase. The reason for this increase is due to the rise in demand for immunology medicines such as Skyrizi and Rinvoq during the Covid-19 pandemic.

An analysis of the region-wise revenue of the company is discussed below.

  • United States: A majority of Abbvie’s revenue comes from the United States, which contributed about 76% of total revenue in FY 2020 amounting to $34.88 billion. There was a 46% increase in revenue compared to FY 2019 where the revenue generated was $23.91 billion.
  • Other countries: This region was the second biggest market for Abbvie Inc. during FY 2020 as it contributed about 9% of the company’s total revenue. There was a 0.25 % fall in the company’s revenue in FY 2020 to $3.98 billion, from $3.99 billion in FY 2019.
  • Germany: During FY 2020, Germany contributed about 1% of the company’s total revenue. There was a decrease in the company’s revenue from this region, from $0.91 billion in FY 2019 to $0.79 billion in FY 2020.
  • Canada: The Canadian region contributed only about 1% of the total revenue of Abbvie during FY 2020. This region’s revenue fell from $0.81 billion in FY 2019 to $0.41 billion in FY 2020.
  • China: China contributed about 3% of Abbvie’s total revenue during FY 2020. The company did not earn any revenue from this region in FY 2019, while in FY 2020, it earned a revenue of $1.16 billion.
  • France: This region contributed 1% of the total revenue in FY 2020. Its revenue fell from $0.69 billion in FY 2019 to $0.47 billion in FY 2020, which is a decrease of 32%.
  • Brazil: Brazil contributed 1% of total revenue in FY 2020 amounting to $0.53 billion. There was a 47% increase in revenue compared to FY 2019 where the revenue generated was $0.36 billion.
  • Japan: Despite being considered the economic powerhouse of Asia, the revenues for Abbvie products from Japan were lower than that from China during FY 2020. This region contributed 1% of the total revenue during FY 2020. The revenues from Japan during FY 2020 fell to $0.38 billion compared to FY 2019 when the revenue was $1.21 billion.
  • Italy: During FY 2020, Italy contributed about 2% of the company’s total revenue. There was an increase in the company’s revenue from this region, from $0.37 billion in FY 2019 to $1.05 billion in FY 2020.
  • Spain: This region contributed 3% of the total revenue in FY 2020. Its revenue grew from $0.47 billion in FY 2019 to $1.19 billion in FY 2020, which increase by 19%.
  • The Netherlands: The Netherlands contributed 1% of total revenue in FY 2020 amounting to $0.45 billion. There was a 136% increase in revenue compared to FY 2019 where the revenue generated was $0.19 billion.
  • United Kingdom: Despite being considered the economic powerhouse of Europe, the revenues for Abbvie products from the United Kingdom were lower than that from Spain during FY 2020. This region contributed 1% of the total revenue during FY 2020. The revenues from the United Kingdom during FY 2020 increased to $0.51 billion compared to FY 2019 when the revenue was $0.37 billion.
  • Company Overview

Abbvie, a public limited company, originated due to a spin-off of Abbott Laboratories in 2013. It is headquartered in Lake Bluff, Illinois. They deal in Pharmaceutical drugs such as Humira, Skyrizi, Imbruvica, Venclexta, Zinbryta, Kaletra, Norvir, and Mavyret. Abbvie Inc’s key managerial persons are Richard A. Gonzalez(Chairman and CEO), and Michael Severino(Vice Chairman and President). As of 2020, the number of employees of the company worldwide was 47,000.  The competitors of Abbvie are Johnson & Johnson, Roche, Merck and Pfizer. The common stocks of Abbvie are listed on the New York Stock Exchange under the trading symbol “ABBV”.

Did you like Abbvie’s Revenue by Region statistic?

Access thousands of more such key performance indicator data points, on listed companies, with Business Quant.

You can also get started for free.

Read more

Our Plans

Always know what you’ll pay. No hidden costs or surprises.

  • Annual
  • Monthly

Basic

Get to know us

  • Access basic data
  • No credit card required
$0
per month
Start for Free

Investor

The essentials toolkit

  • Financial data & tools Features include : Stock screener, stock comparison, sector data, investor warnings, advanced charting tools, financial statements dating back 10+ years, stock reports, SEC filings and stock ratings. There are 200+ financial items and ratios on thousands of US stocks.
  • Download data Download underlying data in csv and xlsx (Excel) formats for offline analysis.
  • Priority support Fanatical 24*7 customer support to ensure seamless access for you.
$19
$9.9
per month*
Buy Now

51% discount until July 31

Pro

For serious investing

  • All of Investor plan All the features in Investor plan, are included in the Pro plan.
  • Granular data & tools Over 100,000 company-specific key performance indicator statistics. Examples include AT&T's broadband subscriber trends, Tesla's deliveries by model and more. Also, access financials by segment / region / product category etc.
  • Industry data & tools Access data on 40+ industries. For example, datasets include market share, smartphone shipments by vendor, subscribers by wireless carrier, historical gold production. There are 20,000+ such statistics.
$39
$19
per month*
Buy Now

Enterprise

For tailored workflows

  • All of Pro plan Get unfettered access to all our dashboards and dossiers.
  • Custom Dashboards Get tailored dashboards built specially for you, to simplify your research workflow.
  • Bespoke Research We'll expand our granular coverage to companies and sectors of your choice.
$99
per month, onwards*
Contact Us

* Billed annually, local taxes extra. 

Basic

Get to know us

  • Access basic data
  • No credit card required
$0
per month
Start for Free

Investor

The essentials toolkit

  • Financial data & tools Features include : Stock screener, stock comparison, sector data, investor warnings, advanced charting tools, financial statements dating back 10+ years, stock reports, SEC filings and stock ratings. There are 200+ financial items and ratios on thousands of US stocks.
  • Download data Download underlying data in csv and xlsx (Excel) formats for offline analysis.
  • Priority support Fanatical 24*7 customer support to ensure seamless access for you.
$19
per month*
Buy Now

51% discount on Annual plan

Pro

For serious investing

  • All of Investor plan All the features in Investor plan, are included in the Pro plan.
  • Granular data & tools Over 100,000 company-specific key performance indicator statistics. Examples include AT&T's broadband subscriber trends, Tesla's deliveries by model and more. Also, access financials by segment / region / product category etc.
  • Industry data & tools Access data on 40+ industries. For example, datasets include market share, smartphone shipments by vendor, subscribers by wireless carrier, historical gold production. There are 20,000+ such statistics.
$39
per month*
Buy Now

Enterprise

For tailored workflows

  • All of Pro plan Get unfettered access to all our dashboards and dossiers.
  • Custom Dashboards Get tailored dashboards built specially for you, to simplify your research workflow.
  • Bespoke Research We'll expand our granular coverage to companies and sectors of your choice.
$99
per month, onwards*
Contact Us

* Local taxes extra. 

BQ Star 51% off

Get Pro for 51% off

  • Access all features immediately
  • Datasets updated every day
  • Export data in CSV and XLSX formats

Offer Ends In

Starting from $39 $10 / month

.